Dismay at drug company push for govt subsidy
AN open letter from dabigatran (Pradaxa) manufacturer Boehringer Ingelheim (BI) published in medical newspapers this week urges GPs to petition the government via a website, Vote Against Stroke.
Similar unbranded communications targeted to consumers were planned, a company spokesperson said.
Dr Evan Ackermann, chair of the RACGP’s national standing committee on quality care, said the campaign represented “appalling behaviour”.
“I think it’s quite inappropriate to drum up support, whether it’s within the public [domain] or within the doctors’ group, to pressure the [government] into doing this sort of thing,” Dr Ackermann said.
Professor Simon Chapman, from the University of Sydney’s school of public health, said BI’s tactics were “really inappropriate”.
“There are only two countries in the